focus -WSS

focus

author：focus 2025-09-27 23:51:58 - browse：65462

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The Danish pharmaceutical company Novo Nordisk has shepherded all kinds of medical innovation in the 110 years since it was founded. But the booming success of its diabetes and obesity drug is unlike anything executives have seen before.

The company’s mid-year operating profit jumped from 37.5 billion Danish kroner in 2022 to 48.9 billion Danish kroner this year — “probably the strongest growth in the history of the company,” Chief Financial Officer Karsten Munk Knudsen said during an August earnings call. The 30% growth rate came from sales of semaglutide, which Novo Nordisk sells for diabetes under the name Ozempic and for obesity as Wegovy.

With its new blockbuster drug in hand, Novo Nordisk is valued higher than the entire economy of Denmark, where it’s based.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： HHS's proposed rule does nothing to address the climate crisis

WSS

Lawmakers grill UnitedHealth CEO on Change cyberattack

HHS's proposed rule does nothing to address the climate crisis

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

Empower primary care with adequate payments and technology

Novel spinal cord stimulator treats paralysis without surgery

Primary care doctor shortage won't be solved by free med school tuition

Wikipedia

focus

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

Charles Manson follower Leslie Van Houten released from prison after 53 years

Moonlake's readout produced a cash windfall. Risks remain

Can gargling with Listerine treat gonorrhea of the mouth?

BioMarin wins approval for gene therapy to treat hemophilia A

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Medical leaders decry Supreme Court decision on affirmative action

Why 40% Americans with Parkinson’s don’t see a neurologist

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

N.Y. state detects polio case, first in the U.S. since 2013

focus

As billionaires fund anti

Has Bernie Sanders reached the limit of his pharma bullying effort?

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Biden launches a new push to limit health care costs

Living with Fabry disease, a condition that causes chronic pain

Oak trusses raised to roof of fire

leisure time

hotspot

Wikipedia

leisure time